Acambis Granted Fast Track Status for ACAM2000 Smallpox Vaccine
CAMBRIDGE, England and CAMBRIDGE, Mass. -- Acambis plc (Acambis) announced that its investigational smallpox vaccine ACAM2000 has been designated as a Fast Track product by the U.S. Food and Drug Administration (FDA).
Acambis has delivered 182.5 million doses of ACAM2000 to the U.S. government for its emergency-use Strategic National Stockpile and has orders from several other governments around the world for its investigational smallpox vaccine.
Acambis is currently proceeding toward the submission of a Biologics License Application (BLA) for ACAM2000 based upon data obtained in all ACAM2000 trials conducted, including clinical data from more than 2,900 subjects vaccinated in its phase 3 clinical trials.
Under the FDA Modernization Act of 1997, designation as a Fast Track product for a new drug or biological product means that FDA will take such actions as are appropriate to expedite the marketing application and approval for the product.
Acambis is working with Baxter Healthcare Corporation, part of Baxter International, Inc., to manufacture its investigational ACAM2000 for the United States and other governments, under the FDA's Investigational New Drug application for ACAM2000.
Source: Acambis plc
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
